Related Experiment Video
Updated: Oct 13, 2025
04:53
A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
10.8K
Parenteral nutrition compatibility and stability: A comprehensive review
Joseph I Boullata1, Jay M Mirtallo2,3, Gordon S Sacks4
1Clinical Nutrition Support Services, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
JPEN. Journal of Parenteral and Enteral Nutrition
|November 17, 2021
Summary
Pharmacists play a crucial role in parenteral nutrition (PN) safety by verifying PN orders. This article details PN component characteristics and compatibility issues to prevent errors during admixture preparation.
Area of Science:
- Clinical Pharmacy
- Nutritional Support
- Patient Safety
Background:
- Parenteral nutrition (PN) administration requires adherence to best practices for patient safety.
- Pharmacist review of PN orders is a critical safety checkpoint.
- Assessing compatibility and stability is essential before PN admixture preparation.
Purpose of the Study:
- To provide working definitions for PN components.
- To describe characteristics of PN components.
- To present compatibility and stability concerns in PN admixtures.
Main Methods:
- Literature review of PN compatibility and stability data.
- Synthesis of information on PN component characteristics.
- Development of a framework for assessing PN prescription risks.
Main Results:
- Detailed descriptions of PN components and their properties.
- Identification of common and critical compatibility and stability issues.
- Guidance on factors influencing PN admixture stability.
Conclusions:
- Pharmacists must possess a thorough understanding of PN components and their interactions.
- Proactive assessment of compatibility and stability is vital for safe PN preparation.
- This article serves as a resource for pharmacists to optimize PN safety.
Related Concept Videos
01:27Parentral Nutrition: Centeral and Peripheral Parental Nutrition
349
Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
349
01:15Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding
342
Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
342
01:05Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
11
Body:Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
11
01:22Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
14
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
14
01:26Enteral Nutrition I: Orogastric and Nasogastric Feeding
543
Enteral nutrition delivers nutrients directly to the stomach or small intestine through a tube. This method is appropriate for patients who cannot eat but still have a functioning digestive system. It is also beneficial for individuals with swallowing difficulties, anorexia, malabsorption, or those who have undergone gastrointestinal (GI) surgery.
Orogastric (OG) and nasogastric (NG) feeding are two standard methods used for enteral nutrition. Enteral nutrition is often preferred over...
Orogastric (OG) and nasogastric (NG) feeding are two standard methods used for enteral nutrition. Enteral nutrition is often preferred over...
543
01:17Bioavailability: Overview
25
Bioavailability refers to the proportion of an administered drug that reaches the systemic circulation in its active, unaltered form. It is a crucial pharmacokinetic parameter that determines the effectiveness of a drug in achieving its intended therapeutic outcomes. The route of administration significantly influences bioavailability, with intravenous administration achieving 100% bioavailability as the drug directly enters the bloodstream. In contrast, oral administration often results in...
25